戻る Agenda
Innovations in Proactive Quality Management: Best Practices and Variability in Approaches to Proactive Quality Management
Session Chair(s)
Steven B. Whittaker
Executive Director, Quality Consortium
The Avoca Group, United States
This forum will explore industry best practices and the variability in industry approaches to quality management. Data from the 2012 Quality Consortium Assessment research will be shared. A panel of industry experts and representatives from the FDA and EMA will provide their perspectives.
Learning Objective : Discuss different approaches being used by the industry in proactive quality management; Describe how companies measure and implement quality standards; Identify tools for proactive quality management.
Speaker(s)
Panelist
Jennifer G. Marsh
Eli Lilly and Company, United States
Senior Director, Global Medical Quality
Panelist
Coleen Glessner, MBA
Alexion Pharmaceuticals, United States
Senior Vice President, Chief Quality Officer
Panelist
Ann Meeker-O'Connell, MS
Novartis, United States
Executive Director, Monitoring Excellence Head
Panelist
Fergus Sweeney, PHD
European Medicines Agency, Netherlands
Head of Clinical Studies and Manufacturing Task Force
Panelist
Cassandra Kennedy
Quintiles Inc., United States
Senior Vice President, Global Quality Assurance